Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
about
Trial watch: Dendritic cell-based anticancer therapyStudy of the cytotoxic/toxic potential of the novel anticancer selenodiazoloquinolone on fibroblast cells and 3D skin model.Assessment of Immunomodulatory Activities and in vitro Toxicity of New Quinolone 7-ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5]selenadiazolo[3,4-h]quinoline-7-carboxylate.Progress in the mechanism and drug development of castration-resistant prostate cancer.Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse.
P2860
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
@en
type
label
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
@en
prefLabel
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer.
@en
P2860
P1476
Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer
@en
P2093
Roberto Pili
P2860
P2888
P356
10.1007/S11912-013-0295-7
P50
P577
2013-04-01T00:00:00Z
P6179
1045487270